Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.450
-0.070 (-4.61%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Autolus Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Autolus Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $8.55. The average 1-year stock price forecast is 489.66% higher than the current stock price, while the lowest is $5.00 (+244.83%) and the highest is $11 (+658.62%).
Price Target: $8.55 (+489.66%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Autolus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 9 | 8 | 8 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 10 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $10 | Buy | Maintains | $10 | +589.66% | Jul 13, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Maintains $10 | Buy | Maintains | $10 | +589.66% | Jun 10, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Buy Reiterates $5 | Buy | Reiterates | $5 | +244.83% | May 15, 2026 |
Unknown Analyst Goldman Sachs No rating | Goldman Sachs | Buy Reiterates $6.1 → $5.4 | Buy | Reiterates | $6.1 → $5.4 | +272.41% | May 15, 2026 |
Financial Forecast
Revenue This Year
128.58M
from 75.39M
Increased by 70.56%
Revenue Next Year
190.98M
from 128.58M
Increased by 48.53%
EPS This Year
-0.89
from -1.08
EPS Next Year
-0.61
from -0.89
EPS and Forward PE are based on non-GAAP adjusted numbers.